awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53384579-89F4273D-5B3E-4B47-9FD5-43B5F5C850A7
Q53384579-89F4273D-5B3E-4B47-9FD5-43B5F5C850A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53384579-89F4273D-5B3E-4B47-9FD5-43B5F5C850A7
Breast cancer: weekly paclitaxel--still preferred first-line taxane for mBC.
P2860
Q53384579-89F4273D-5B3E-4B47-9FD5-43B5F5C850A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53384579-89F4273D-5B3E-4B47-9FD5-43B5F5C850A7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5fca1eba7acab5a3b7e1415fe85340667ec067ec
P2860
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.